Skip to main content
×
×
Home

The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension

  • Adam T. James (a1), John D. Corcoran (a1), Patrick J. McNamara (a2) (a3), Orla Franklin (a4) and Afif F. El-Khuffash (a1) (a5)...
Abstract
Introduction

Milrinone may be an appropriate adjuvant therapy for infants with persistent pulmonary hypertension of the newborn. We aimed to describe the effect of milrinone administration on right and left ventricular function in infants with persistent pulmonary hypertension not responding to inhaled nitric oxide after 4 hours of administration.

Materials and methods

This is a retrospective review of infants born after or at 34 weeks of gestation with persistent pulmonary hypertension who received milrinone treatment. The primary endpoint was the effect of milrinone on myocardial performance and haemodynamics, including right and left ventricular outputs, tissue Doppler velocities, right ventricle and septal strain, and strain rate. Secondary endpoints examined included duration of inhaled nitric oxide and oxygen support.

Results

A total of 17 infants with a mean (standard deviation) gestation and birth weight of 39.8 (2.0) weeks and 3.45 (0.39) kilograms, respectively, were included in the study. The first echocardiogram was performed 15 hours after the commencement of nitric oxide inhalation. Milrinone treatment was started at a median time of 1 hour after the echocardiogram and was associated with an increase in left ventricular output (p=0.04), right ventricular output (p=0.004), right ventricle strain (p=0.01) and strain rate (p=0.002), and left ventricle s` (p<0.001) and a` (p=0.02) waves. There was a reduction in nitric oxide dose and oxygen requirement over the subsequent 72 hours (all p<0.05).

Conclusion

The use of milrinone as an adjunct to nitric oxide is worth further exploration, with preliminary evidence suggesting an improvement in both oxygenation and myocardial performance in this group of infants.

Copyright
Corresponding author
Correspondence to: Dr A. El-Khuffash FRCPI, MD, DCE, Consultant Neonatologist, The Rotunda Hospital, Parnell Street, Dublin 1, Ireland. Tel: +353 1 873 0700; Fax: +353 1 872 6523; E-mail: afif@physicians.ie
References
Hide All
1. Lipkin, PH, Davidson, D, Spivak, L, Straube, R, Rhines, J, Chang, CT. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2002; 140: 306310.
2. Walsh-Sukys, MC, Tyson, JE, Wright, LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000; 105: 1420.
3. Haworth, SG, Reid, L. Persistent fetal circulation: newly recognized structural features. J Pediatr 1976; 88: 614620.
4. Sehgal, A, Athikarisamy, SE, Adamopoulos, M. Global myocardial function is compromised in infants with pulmonary hypertension. Acta Paediatr 2012; 101: 410413.
5. Evans, N, Kluckow, M, Currie, A. Range of echocardiographic findings in term neonates with high oxygen requirements. Arch Dis Child Fetal Neonatal Ed 1998; 78: F105F111.
6. Peterson, AL, Deatsman, S, Frommelt, MA, Mussatto, K, Frommelt, PC. Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn. Pediatr Cardiol 2009; 30: 160165.
7. Musewe, NN, Poppe, D, Smallhorn, JF, et al. Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn. J Am Coll Cardiol 1990; 15: 446456.
8. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336: 597604.
9. Goldman, AP, Tasker, RC, Haworth, SG, Sigston, PE, Macrae, DJ. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1996; 98: 706713.
10. Silver, PJ, Harris, AL, Canniff, PC, et al. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. J Cardiovasc Pharmacol 1989; 13: 530540.
11. LeJemtel, TH, Scortichini, D, Levitt, B, Sonnenblick, EH. Effects of phosphodiesterase inhibition on skeletal muscle vasculature. Am J Cardiol 1989; 63: 27A30A.
12. McNamara, PJ, Laique, F, Muang-In, S, Whyte, HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006; 21: 217222.
13. Bassler, D, Choong, K, McNamara, P, Kirpalani, H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006; 89: 15.
14. McNamara, PJ, Shivananda, SP, Sahni, M, Freeman, D, Taddio, A. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. Pediatr Crit Care Med 2013; 14: 7484.
15. Poon, CY, Edwards, JM, Joshi, S, Kotecha, S, Fraser, AG. Optimization of myocardial deformation imaging in term and preterm infants. Eur J Echocardiogr 2011; 12: 247254.
16. Joshi, S, Edwards, JM, Wilson, DG, Wong, JK, Kotecha, S, Fraser, AG. Reproducibility of myocardial velocity and deformation imaging in term and preterm infants. Eur J Echocardiogr 2010; 11: 4450.
17. Nestaas, E, Stoylen, A, Sandvik, L, Brunvand, L, Fugelseth, D. Feasibility and reliability of strain and strain rate measurement in neonates by optimizing the analysis parameters settings. Ultrasound Med Biol 2007; 33: 270278.
18. Mertens, L, Seri, I, Marek, J, et al. Targeted neonatal echocardiography in the neonatal intensive care unit: practice guidelines and recommendations for training writing group of the American Society of Echocardiography (ASE) in collaboration with the European Association of Echocardiography (EAE) and the Association for European Pediatric Cardiologists (AEPC). J Am Soc Echocardiogr 2011; 24: 10571078.
19. Lopez, L, Colan, SD, Frommelt, PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the pediatric measurements writing group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010; 23: 465495.
20. James, A, Corcoran, D, Jain, A, et al. PC.40 assessment of myocardial performance using novel echocardiography markers in infants less than 29 weeks gestation during the transitional period. Arch Dis Child Fetal Neonatal Ed 2014; 99 (Suppl 1): A49A50.
21. Harada, K, Tamura, M, Toyono, M, Yasuoka, K. Comparison of the right ventricular tei index by tissue Doppler imaging to that obtained by pulsed Doppler in children without heart disease. Am J Cardiol 2002; 90: 566569.
22. Jaillard, S, Houfflin-Debarge, V, Riou, Y, et al. Effects of catecholamines on the pulmonary circulation in the ovine fetus. Am J Physiol Regul Integr Comp Physiol 2001; 281: R607R614.
23. Cheung, PY, Barrington, KJ. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care 2001; 5: 158166.
24. Jain, A, Mohamed, A, EL-Khuffash, A, et al. A comprehensive echocardiographic protocol for assessing neonatal right ventricular dimensions and function in the transitional period: normative data and z-scores. J Am Soc Echocardiogr 2014; 27: 12931304.
25. Hoffman, TM, Wernovsky, G, Atz, AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 9961002.
26. Jain, A, Sahni, M, El-Khuffash, A, Khadawardi, E, Sehgal, A, McNamara, PJ. Use of targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus arteriosus ligation. J Pediatr 2012; 160: 584589.
27. Deb, B, Bradford, K, Pearl, RG. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 2000; 28: 795799.
28. Khazin, V, Kaufman, Y, Zabeeda, D, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 2004; 18: 156159.
29. Amoozgar, H, Tavakkoli, F, Ajami, GH, Borzoee, M, Basiratnia, M. Preload dependence of Doppler tissue imaging-derived indices in adolescents. Pediatr Nephrol 2008; 23: 18031808.
30. El-Khuffash, AF, Jain, A, Weisz, D, Mertens, L, McNamara, PJ. Assessment and treatment of post patent ductus arteriosus ligation syndrome. J Pediatr 2014; 165: 4652.
31. El-Khuffash, AF, Jain, A, Dragulescu, A, McNamara, PJ, Mertens, L. Acute changes in myocardial systolic function in preterm infants undergoing patent ductus arteriosus ligation: a tissue Doppler and myocardial deformation study. J Am Soc Echocardiogr 2012; 25: 10581067.
32. Bassler, D, Kreutzer, K, McNamara, P, Kirpalani, H. Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev 2010; (11): CD007802.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Cardiology in the Young
  • ISSN: 1047-9511
  • EISSN: 1467-1107
  • URL: /core/journals/cardiology-in-the-young
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed